These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18972429)

  • 1. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial.
    Ackerstaff AH; Balm AJ; Rasch CR; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hilgers FJ
    Head Neck; 2009 Jan; 31(1):77-84. PubMed ID: 18972429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer.
    Ackerstaff AH; Rasch CR; Balm AJ; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hauptmann M; Vincent A; Hilgers FJ
    Head Neck; 2012 Jul; 34(7):974-80. PubMed ID: 21818820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I; Robbins KT; Samant S; Vieira F
    World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.
    van den Broek GB; Balm AJ; van den Brekel MW; Hauptmann M; Schornagel JH; Rasch CR
    Radiother Oncol; 2006 Nov; 81(2):143-50. PubMed ID: 17055096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.
    Balm AJ; Rasch CR; Schornagel JH; Hilgers FJ; Keus RB; Schultze-Kool L; Ackerstaff AH; Busschers W; Tan IB
    Head Neck; 2004 Jun; 26(6):485-93. PubMed ID: 15162349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.
    El-Deiry M; Funk GF; Nalwa S; Karnell LH; Smith RB; Buatti JM; Hoffman HT; Clamon GH; Graham SM; Trask DK; Dornfeld KJ; Yao M
    Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):879-85. PubMed ID: 16230590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma.
    Ackerstaff AH; Tan IB; Rasch CR; Balm AJ; Keus RB; Schornagel JH; Hilgers FJ
    Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1185-90. PubMed ID: 12365891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck.
    Rabbani A; Hinerman RW; Schmalfuss IM; Amdur RJ; Morris CG; Peters KR; Robbins KT; Mendenhall WM
    Am J Clin Oncol; 2007 Jun; 30(3):283-6. PubMed ID: 17551306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Karlsson U; Nguyen P; Dutta S; Lemanski C; Ludin A; Rose S; Nguyen LM; Ward H; Huang S; Sallah S
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):271-6. PubMed ID: 17565229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
    Liu J; Tu D; Dancey J; Reyno L; Pritchard KI; Pater J; Seymour LK
    Breast Cancer Res Treat; 2006 Dec; 100(3):263-71. PubMed ID: 16823511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial.
    Rasch CR; Hauptmann M; Schornagel J; Wijers O; Buter J; Gregor T; Wiggenraad R; de Boer JP; Ackerstaff AH; Kroger R; Hoebers FJ; Balm AJ; Hilgers FJ
    Cancer; 2010 May; 116(9):2159-65. PubMed ID: 20187094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT).
    Robbins KT; Samant S; Vieira F; Kumar P
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):28-32. PubMed ID: 14732764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of treatment on quality of life for oral and oropharyngeal carcinoma.
    Infante-Cossio P; Torres-Carranza E; Cayuela A; Hens-Aumente E; Pastor-Gaitan P; Gutierrez-Perez JL
    Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1052-8. PubMed ID: 19596557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.
    Ravasco P; Monteiro-Grillo I; Marques Vidal P; Camilo ME
    Head Neck; 2005 Aug; 27(8):659-68. PubMed ID: 15920748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer.
    Nomura K; Takahara M; Katayama A; Kishibe K; Kunibe I; Katada A; Hayashi T; Harabuchi Y
    Laryngoscope; 2013 Apr; 123(4):916-22. PubMed ID: 23280966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life after simultaneous radiochemotherapy in squamous cell carcinoma of the head and neck].
    Wendt TG
    Strahlenther Onkol; 2000 Apr; 176(4):198-200. PubMed ID: 10812396
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
    Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.